Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMOJEV in healthy Vietnamese subjects
NCT02492165Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2015
- Primary completion
- Mar 2016
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of japanese encephalitis chimeric virus vaccine in Japanese encephalitis (JE), sponsored by Sanofi. Started Jun 2015; status: completed.
02
Drugs
japanese encephalitis chimeric virus vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT02492165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492165.